Ionis Pharmaceuticals, Inc. IONS
44.50
0.69
1.57%
as of 25 Sep
- Market cap
- $7.4B
- P/E
- 0.0×
Follow IONS
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 28.50 | 27.17 | 723.20 | 0.00 |
P/S ratio |
13.41 | 7.41 | 9.61 | 9.08 | 5.29 | 10.82 | 7.53 | 11.93 | 11.88 | 15.36 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 367.72 | 0.00 | 27.34 | 12.22 | 44.81 | 0.00 |
P/Operating CF |
(91.92) | (45.01) | 230.35 | (26.63) | 21.07 | 80.57 | 30.44 | 61.93 | 299.39 | (213.31) |
P/B ratio |
25.88 | 8.88 | 19.58 | 9.30 | 5.56 | 10.62 | 5.02 | 6.03 | 16.72 | 57.50 |
Price to Tangible BV |
27.55 | 9.35 | 21.20 | 9.81 | 5.78 | 11.03 | 5.10 | 6.15 | 17.79 | 72.29 |
EV/Sales |
12.46 | 5.98 | 8.27 | 7.72 | 4.21 | 9.52 | 6.01 | 9.53 | 11.07 | 14.96 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 281.50 | 0.00 | 17.88 | 0.00 | 69.13 | 202.83 |
EV/Operating CF |
(43.79) | (8.42) | (21.18) | (16.53) | 110.67 | 193.38 | 19.52 | 9.48 | 32.69 | (49.74) |
EV/FCF |
(36.11) | (7.65) | (19.41) | (108.29) | 292.06 | (1,346.18) | 21.81 | 9.77 | 41.77 | (45.11) |
Quick Ratio |
3.51 | 7.73 | 5.42 | 6.46 | 9.05 | 3.29 | 9.39 | 7.48 | 4.46 | 5.78 |
Current Ratio |
3.83 | 8.47 | 5.90 | 7.07 | 9.75 | 3.56 | 9.97 | 7.88 | 4.80 | 5.96 |
Net Debt/EBITDA |
2.39 | 2.17 | 2.99 | 2.12 | (72.92) | 6.80 | (4.54) | 97.89 | (5.04) | (5.40) |
Debt/Assets |
50.50% | 41.47% | 42.60% | 46.99% | 47.18% | 39.32% | 24.36% | 24.24% | 45.92% | 56.63% |
Debt/Equity |
3.64 | 2.12 | 3.29 | 2.08 | 1.60 | 1.26 | 0.47 | 0.54 | 1.66 | 5.19 |
Asset Turnover |
0.29 | 0.24 | 0.29 | 0.23 | 0.32 | 0.26 | 0.38 | 0.30 | 0.46 | 0.40 |
Operating CF/Net income |
0.70 | 1.10 | 0.84 | 1.02 | (1.08) | (0.08) | 1.24 | 2.20 | 503.32 | 1.86 |
Capex/Depreciation |
(9.73) | 5.56 | 491.04 | 6.71 | (0.42) | (1.29) | (3.17) | (0.38) | (0.74) | (0.24) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (70.80%) | (93.10%) | (76.34%) | (40.12%) | (3.78%) | (36.60%) | 19.37% | 35.27% | 0.15% | (40.22%) | |
| (11.69%) | (15.15%) | (13.26%) | (10.48%) | (1.14%) | (15.80%) | 9.43% | 13.72% | 0.03% | (6.49%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(16.35%) | (18.87%) | (16.17%) | (13.72%) | (1.25%) | (25.94%) | 10.69% | 13.29% | 0.03% | (7.98%) |
Average Days of Receivables |
25.55 | 47.72 | 45.31 | 15.87 | 27.88 | 38.14 | 20.49 | 7.77 | 44.69 | 105.79 |
Research and Development Expense of Revenue |
97.02% | 127.85% | 114.22% | 141.84% | 79.39% | 73.37% | 41.48% | 69.14% | 72.86% | 92.37% |
Selling, General and Administrative Expense of Revenue |
41.74% | 37.93% | 29.53% | 25.59% | 22.99% | 48.59% | 25.53% | 40.79% | 21.10% | 13.04% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 |
Share Based Compensation of Revenue |
14.19% | 18.46% | 13.43% | 17.07% | 14.89% | 31.55% | 13.06% | 21.90% | 16.72% | 19.34% |
Graham Net Nets |
0.00 | 0.04 | 0.01 | 0.05 | 0.12 | 0.06 | 0.14 | 0.10 | 0.03 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 23.96 | 20.04 | 2.12 | 0.00 |
Earnings Yield |
(2.98%) | (8.70%) | (4.84%) | (5.06%) | (0.66%) | (5.73%) | 3.51% | 3.68% | 0.14% | (1.05%) |
Free Cash Flow Yield |
(2.57%) | (10.55%) | (4.43%) | (0.79%) | 0.27% | (0.07%) | 3.66% | 8.18% | 2.23% | (2.16%) |
Revenue per Share |
5.90 | 4.72 | 5.50 | 4.14 | 5.75 | 5.22 | 8.02 | 4.53 | 4.15 | 3.08 |
Operating CF per Share |
(1.68) | (3.35) | (2.15) | (1.93) | 0.22 | 0.26 | 2.47 | 4.56 | 1.40 | (0.93) |
Capex per Share |
(0.36) | (0.34) | (0.20) | 1.65 | (0.13) | (0.29) | (0.26) | (0.13) | (0.31) | (0.10) |
Free Cash Flow per Share |
(2.04) | (3.69) | (2.34) | (0.28) | 0.09 | (0.04) | 2.21 | 4.42 | 1.10 | (1.02) |
Cash per Share |
16.73 | 15.37 | 16.28 | 14.01 | 15.00 | 13.55 | 17.85 | 15.75 | 8.25 | 5.50 |
Shareholders Equity per Share |
3.06 | 3.94 | 2.70 | 4.04 | 5.47 | 5.32 | 12.03 | 8.97 | 2.95 | 0.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.06 | 3.94 | 2.70 | 4.04 | 5.47 | 5.32 | 12.03 | 8.97 | 2.95 | 0.82 |
Free Cash Flow |
(325.67) | (551.29) | (335.50) | (40.39) | 12.90 | (5.16) | 309.35 | 585.25 | 136.29 | (123.63) |
Working Capital |
2,209.07 | 2,310.97 | 2,193.76 | 1,891.13 | 2,104.50 | 1,531.81 | 2,447.59 | 1,927.59 | 925.12 | 664.15 |
Capital Expenditures |
(57.08) | (50.34) | (27.99) | 233.98 | (17.90) | (41.05) | (36.28) | (17.65) | (37.86) | (11.53) |
Net Current Asset Value |
(44.11) | 204.97 | 38.47 | 241.71 | 505.10 | 484.23 | 1,172.03 | 727.26 | 211.24 | (14.97) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.44 | 0.00 | 183.35 | 0.00 |
Capex to Sales |
0.06 | 0.07 | 0.04 | (0.40) | 0.02 | 0.06 | 0.03 | 0.03 | 0.07 | 0.03 |
Net Profit Margin |
(40.41%) | (64.37%) | (46.50%) | (45.92%) | (3.53%) | (60.92%) | 24.78% | 45.65% | 0.07% | (16.20%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 23.11 | 0.00 | 196.73 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.05 | (0.10) | 0.00 | 0.47 | 0.24 | 0.18 | 0.07 | 0.35 | 0.42 | 0.51 |
Cash ROIC |
(7.92%) | (14.41%) | (9.48%) | (9.30%) | (3.58%) | (4.06%) | 3.86% | 12.02% | 2.62% | (15.99%) |
Accounts Receivable Turnover |
11.93 | 7.42 | 12.77 | 13.44 | 11.74 | 10.48 | 29.62 | 15.84 | 6.01 | 6.24 |
Accounts Payable Turnover |
0.45 | 0.33 | 0.42 | 0.95 | 0.75 | 0.72 | 0.20 | 0.07 | 0.35 | 0.00 |
Inventory Turnover |
1.41 | 1.12 | 0.62 | 0.60 | 0.46 | 0.60 | 0.33 | 0.20 | 0.92 | 0.00 |
Average Days of Payables |
644.29 | 1,398.29 | 1,040.17 | 463.39 | 400.75 | 525.46 | 1,337.70 | 5,747.75 | 1,135.42 | 0.00 |
Days of Inventory on Hand |
230.53 | 407.21 | 297.38 | 569.71 | 835.10 | 671.07 | 1,513.62 | 1,721.12 | 455.43 | 0.00 |
Average Receivables |
79.12 | 94.98 | 61.66 | 43.72 | 69.05 | 69.62 | 37.90 | 37.86 | 85.50 | 59.70 |
Average Payables |
35.52 | 34.50 | 21.97 | 14.91 | 14.55 | 16.63 | 22.36 | 26.77 | 23.00 | 24.74 |
Average Inventory |
11.28 | 9.98 | 14.74 | 23.42 | 23.39 | 20.07 | 13.38 | 9.28 | 8.74 | 7.19 |
Average Assets |
3,263.76 | 2,996.87 | 2,761.97 | 2,572.78 | 2,500.72 | 2,811.43 | 2,950.45 | 1,995.28 | 1,117.62 | 930.18 |
Average Common Equity |
538.72 | 487.52 | 479.79 | 672.31 | 757.51 | 1,213.91 | 1,435.85 | 776.22 | 232.42 | 150.18 |
Columns are period end dates